← Back to Analyst Consensus 
UHS Hold
UNIVERSAL HEALTH SERVICES INC
Current Price —
Implied Upside —
Analysts 25
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Oct 27, 2026 (1 day)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 18, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 50% |
| Aug 20, 2026 | RBC Capital | reiterate | Sector Perform → Sector Perform | — | 55% |
| Aug 3, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Jul 30, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Jul 29, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 29, 2026 | Cantor Fitzgerald | reiterate | Neutral → Neutral | — | 50% |
| Jul 29, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Jul 28, 2026 | Cantor Fitzgerald | reiterate | Neutral → Neutral | — | 50% |
| Jul 28, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 20, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 13, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 8, 2026 | Barclays | downgrade | Overweight → Equal-Weight | — | 53% |
| Jun 22, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 30, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Apr 29, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 29, 2026 | RBC Capital | maintain | Sector Performer → Sector Perform | — | 55% |
| Apr 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Apr 29, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| Apr 29, 2026 | Baird | maintain | Neutral → Neutral | — | 55% |
| Apr 28, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 2, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Feb 27, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | $229 | 50% |
| Feb 26, 2026 | Barclays | maintain | Overweight → Overweight | $268 | 53% |
| Jan 22, 2026 | Barclays | maintain | Overweight → Overweight | $262 | 53% |
| Jan 7, 2026 | TD Cowen | maintain | Buy → Buy | $245 | 54% |
| Jan 7, 2026 | Wells Fargo | downgrade | Overweight → Equal-Weight | $235 | 54% |
| Dec 2, 2025 | Guggenheim | maintain | Buy → Buy | $274 | 52% |
| Nov 13, 2025 | Wells Fargo | maintain | Overweight → Overweight | $259 | 54% |
| Oct 30, 2025 | RBC Capital | maintain | Sector Perform → Sector Performer | $231 | 55% |
| Oct 29, 2025 | UBS | maintain | Buy → Buy | $302 | 54% |
| Oct 29, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $250 | 50% |
| Oct 29, 2025 | Guggenheim | maintain | Buy → Buy | $253 | 52% |
| Oct 28, 2025 | Barclays | maintain | Overweight → Overweight | $263 | 53% |
| Oct 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $249 | 54% |
| Oct 7, 2025 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $227 | 50% |
| Sep 18, 2025 | Barclays | maintain | Overweight → Overweight | $250 | 53% |
| Aug 26, 2025 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $227 | 50% |
| Aug 19, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $206 | 55% |
| Aug 14, 2025 | Baird | maintain | Neutral → Neutral | $203 | 55% |
| Aug 14, 2025 | Wells Fargo | maintain | Overweight → Overweight | $210 | 54% |
| Aug 4, 2025 | JP Morgan | maintain | Neutral → Neutral | $195 | 55% |
| Jul 30, 2025 | Barclays | maintain | Overweight → Overweight | $259 | 53% |
| Jul 16, 2025 | B of A Securities | downgrade | Neutral → Underperform | $185 | 53% |
| Apr 30, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $201 | 55% |
| Apr 29, 2025 | Barclays | maintain | Overweight → Overweight | $257 | 53% |
| Apr 15, 2025 | Baird | downgrade | Outperform → Neutral | $224 | 55% |
| Apr 9, 2025 | Guggenheim | initiate | — → Buy | $208 | 52% |
| Mar 26, 2025 | Morgan Stanley | initiate | — → Equal-Weight | $200 | 54% |
| Mar 10, 2025 | Wells Fargo | maintain | Overweight → Overweight | $225 | 54% |
Price Target Trend
Jun 29, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days